Aldose reductase, fructose and fat production in the liver
Biochemical Journal · 05.03.2025 · 482 (05) · 295-307
DOI: 10.1042/bcj20240748 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Journal, online erschienen am 19.02.2025. Verfasst von Peter Delannoy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Orgins of Human Metabolic Disease, Phoneix, AZ,85016, U.S.A. Hauptthemen laut MEDLINE: Fructose, Aldehyde Reductase, Liver. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
There is an increasing interest in the role of fructose as a major driver of non-alcoholic fatty liver disease (NAFLD), and it is linked closely with the intake of sugar. However, there has also been the recognition that fructose can be produced directly from intracellular glucose via the evolutionarily conserved polyol pathway whose access is governed by aldose reductase (AR). The purpose of this article is to review the biochemistry of AR and the role of the polyol pathway in opening fructose metabolism. This article provides a new perspective about AR and the other key enzymes surrounding the decision to divert glucose into the polyol pathway which suggests that the production of endogenous fructose may be of much greater significance than historically viewed. There are important aspects of the regulation of the polyol pathway and its committal step catalyzed by AR, which supports the notion that fructose-uric acid pathway is activated by elevated glucose with the downstream consequence of NAFLD and perhaps other chronic metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Orgins of Human Metabolic Disease, Phoneix, AZ,85016, U.S.A.
- Department of Biology, Boston University, Boston, MA, U.S.A.
- Division of Endocrinology, Metabolism and Diabetes, University of Colorado Denver, Aurora, CO, U.S.A.
- Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, U.S.A.
- Molecular Biology, Cell Biology, and Biochemistry Program, Boston University, Boston, U.S.A.
- Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, U.S.A.
ORCID-Profile: Peter Delannoy
Förderung
- NIDDK NIH HHS
Zitieren
APA
Delannoy, P., Tolan, D. R., Lanaspa, M. A., San Millán, I., Bae, S. Y., & Johnson, R. J. (2025). Aldose reductase, fructose and fat production in the liver. Biochemical Journal, 482(05), 295-307. https://doi.org/10.1042/bcj20240748
Vancouver
Delannoy P, Tolan DR, Lanaspa MA, San Millán I, Bae SY, Johnson RJ. Aldose reductase, fructose and fat production in the liver. Biochemical Journal. 2025;482(05):295-307. doi:10.1042/bcj20240748
BibTeX
@article{Delannoy2025,
author = {Delannoy, Peter and Tolan, Dean R and Lanaspa, Miguel A and San Millán, Iñigo and Bae, So Young and Johnson, Richard J},
title = {Aldose reductase, fructose and fat production in the liver},
journal = {Biochemical Journal},
year = {2025},
volume = {482},
number = {05},
pages = {295--307},
doi = {10.1042/bcj20240748}
}
EUVIMED